Search results
Results from the WOW.Com Content Network
Factor V Leiden is an autosomal dominant genetic condition that exhibits incomplete penetrance, i.e. not every person who has the mutation develops the disease. The condition results in a factor V variant that cannot be as easily degraded by activated protein C. The gene that codes the protein is referred to as F5.
14067 Ensembl ENSG00000198734 ENSMUSG00000026579 UniProt P12259 O88783 RefSeq (mRNA) NM_000130 NM_007976 RefSeq (protein) NP_000121 NP_032002 Location (UCSC) Chr 1: 169.51 – 169.59 Mb Chr 1: 163.98 – 164.05 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Coagulation factor V (Factor V), also less commonly known as proaccelerin or labile factor, is a protein involved in ...
APC resistance is the inability of protein C to cleave Factor Va and/or Factor VIIIa, which allows for longer duration of thrombin generation and may lead to a hypercoagulable state. This may be hereditary or acquired. [4] The best known and most common hereditary form is Factor V Leiden, which is responsible for more than 95% of cases. [5]
The minor ("type 2") thrombophilias are much more common. Factor V Leiden is present in 5% of the population of Northern European descent, but much rarer in those of Asian or African extraction. In people with thrombosis, 10% have factor V Leiden. In those who are referred for thrombophilia testing, 30–50% have the defect.
Thrombophilias (anti-phospholipid syndrome, protein C/S deficiency, factor V Leiden) Having donated a kidney [4] Pregnancy Multiple gestation (twins or triplets, etc.) [3] Placental abnormalities: Hyperplacentosis: Excessive exposure to chorionic villi; Placental ischemia; Family history Family history of pre-eclampsia
286.3 Congenital deficiency of other clotting factors. Factor XIII deficiency; 286.4 Von Willebrand's disease; 286.5 Hemorrhagic disorder due to intrinsic anticoagulants; 286.6 Defibrination syndrome; 286.7 Acquired coagulation factor deficiency; 286.9 Coagulation defects, other; 287 Purpura and other hemorrhagic conditions. 287.0 Allergic ...
In fact, recent research estimates 40% of girls and young women aged 12 to 21 in the US are affected by iron deficiency, with menstruation listed as the primary risk factor. Pregnancy and ...
Hypoprothrombinemia can be the result of a genetic defect, may be acquired as the result of another disease process, or may be an adverse effect of medication.For example, 5-10% of patients with systemic lupus erythematosus exhibit acquired hypoprothrombinemia due to the presence of autoantibodies which bind to prothrombin and remove it from the bloodstream (lupus anticoagulant ...